SNDX - Syndax initiated Buy at Goldman Sachs citing sales ops next year
2023-10-11 13:35:35 ET
More on Syndax
- Syndax Pharmaceuticals: Positive Axatilimab Phase 2 Results
- Syndax Pharmaceuticals, Inc. (SNDX) Q2 2023 Earnings Call Transcript
- Biggest stock movers today: Arch Resources, Coinbase Global and more
- Syndax Pharma falls after early data for leukemia therapy
- Seeking Alpha’s Quant Rating on Syndax Pharmaceuticals
For further details see:
Syndax initiated Buy at Goldman Sachs citing sales ops next year